Infliximab

Infliximab for Immune Checkpoint Inhibitor Associated AKI

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

A Direct Head-to-head Comparison of Ustekinumab With Infliximab for the Treatment of Ulcerative Colitis

Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing Polychondritis

PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms

TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Anti-Inflammatory Challenge in Schizophrenia

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis